Literature DB >> 14673210

Protein-protein interactions in Cdk5 regulation and function.

Anthony C B Lim1, Dianbo Qu, Robert Z Qi.   

Abstract

Cdk5 is a unique member of the cyclin-dependent kinase (Cdk) family of small protein kinases. In association with its neuron-specific activator p35 or p39, Cdk5 displays many regulatory properties distinct from other Cdks. A growing body of evidence has suggested that Cdk5-p35 has important implications in a variety of neuronal activities occurring in the central nervous system. In brain, Cdk5-p35 appears to exist as large molecular complexes with other proteins, and protein-protein interactions appear to be a molecular principle for Cdk5-p35 to conduct its physiological functions. Over the past decade, a number of proteins have been identified to associate with Cdk5-p35. While the majority of these proteins mediate their interaction with Cdk5 through p35, implying that p35 may act not only as an activator of Cdk5 but also as an adaptor to associate Cdk5 with its regulators and physiological targets, a small group of other proteins are found to link directly with Cdk5. In addition, Cdk5 has been found to phosphorylate a diverse list of substrates, further implicating its regulatory roles in a wide range of cellular processes. In this review, we present an updated inventory of the interacting proteins of Cdk5-p35 kinase and its substrates as well as a discussion on the implicated effects of these interactions. Copyright 2003 S. Karger AG, Basel

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14673210     DOI: 10.1159/000074625

Source DB:  PubMed          Journal:  Neurosignals        ISSN: 1424-862X


  13 in total

1.  A 24-residue peptide (p5), derived from p35, the Cdk5 neuronal activator, specifically inhibits Cdk5-p25 hyperactivity and tau hyperphosphorylation.

Authors:  Ya-Li Zheng; Niranjana D Amin; Ya-Fang Hu; Parvathi Rudrabhatla; Varsha Shukla; Jyotshnabala Kanungo; Sashi Kesavapany; Philip Grant; Wayne Albers; Harish C Pant
Journal:  J Biol Chem       Date:  2010-08-18       Impact factor: 5.157

2.  The neuronal p35 activator of Cdk5 is a novel F-actin binding and bundling protein.

Authors:  Lisheng He; Zhaojun Zhang; Yan Yu; Sohail Ahmed; Nam Sang Cheung; Robert Z Qi
Journal:  Cell Mol Life Sci       Date:  2010-10-26       Impact factor: 9.261

3.  The Cdk5 activator P39 specifically links muskelin to myosin II and regulates stress fiber formation and actin organization in lens.

Authors:  Brajendra K Tripathi; Douglas R Lowy; Peggy S Zelenka
Journal:  Exp Cell Res       Date:  2014-08-13       Impact factor: 3.905

4.  Characterization of the CDK5 gene in Apis cerana cerana (AccCDK5) and a preliminary identification of its activator gene, AccCDK5r1.

Authors:  Guangdong Zhao; Chen Wang; Hongfang Wang; Lijun Gao; Zhenguo Liu; Baohua Xu; Xingqi Guo
Journal:  Cell Stress Chaperones       Date:  2017-07-03       Impact factor: 3.667

5.  Gene expression pattern in PC12 cells with reduced PMCA2 or PMCA3 isoform: selective up-regulation of calmodulin and neuromodulin.

Authors:  Tomasz Boczek; Anna Kozaczuk; Bozena Ferenc; Michalina Kosiorek; Slawomir Pikula; Ludmila Zylinska
Journal:  Mol Cell Biochem       Date:  2011-09-13       Impact factor: 3.396

6.  Identification and Verification of the Ability of Cdk5 to Phosphorylate Deubiquitinating Enzyme BRCC3 In Vitro.

Authors:  C H Zhang; K Qin; S L Tian; Y Han; S Y Xu; X Y Shao
Journal:  Bull Exp Biol Med       Date:  2022-05-03       Impact factor: 0.804

7.  Activated cyclin-dependent kinase 5 promotes microglial phagocytosis of fibrillar β-amyloid by up-regulating lipoprotein lipase expression.

Authors:  Yuanhui Ma; Jintao Bao; Xuyang Zhao; Hongyan Shen; Junniao Lv; Shuaipeng Ma; Xuefei Zhang; Zeyang Li; Shuxin Wang; Qingsong Wang; Jianguo Ji
Journal:  Mol Cell Proteomics       Date:  2013-07-01       Impact factor: 5.911

8.  Negative regulation of cyclin-dependent kinase 5 targets by protein kinase C.

Authors:  Bogachan Sahin; Ammar H Hawasli; Robert W Greene; Jeffery D Molkentin; James A Bibb
Journal:  Eur J Pharmacol       Date:  2008-01-10       Impact factor: 4.432

9.  Actin interaction and regulation of cyclin-dependent kinase 5/p35 complex activity.

Authors:  Jiqing Xu; Koji Tsutsumi; Kiyotaka Tokuraku; Katherine A Estes; Shin-ichi Hisanaga; Tsuneya Ikezu
Journal:  J Neurochem       Date:  2011-01       Impact factor: 5.372

10.  The atypical kinase Cdk5 is activated by insulin, regulates the association between GLUT4 and E-Syt1, and modulates glucose transport in 3T3-L1 adipocytes.

Authors:  Vasiliki Lalioti; Gemma Muruais; Ana Dinarina; Josef van Damme; Joel Vandekerckhove; Ignacio V Sandoval
Journal:  Proc Natl Acad Sci U S A       Date:  2009-03-02       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.